Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MACROGENICS INC | Director | Stock Option (right to buy) | 16.5K | $167K | $10.15 | May 21, 2024 | Direct |
MACROGENICS INC | Director | Restricted Stock Unit | 6.5K | $118K | $18.22 | May 21, 2024 | Direct |
MACROGENICS INC | Director | Common Stock | 4.5K | $82K | $18.22 | May 20, 2024 | Direct |
Spero Therapeutics, Inc. | Director | Common Stock | 55K | $79.8K | $1.45 | May 29, 2024 | Direct |
Mural Oncology plc | Director | Stock Option (right to buy) | 8.46K | $28.3K | $3.35 | May 30, 2024 | Direct |
GLYCOMIMETICS INC | Director | Stock Option (right to buy) | 40K | May 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MURA | Mural Oncology plc | May 30, 2024 | 1 | $0 | 4/A | Jun 5, 2024 | Director |
MURA | Mural Oncology plc | May 30, 2024 | 1 | $28.3K | 4 | Jun 3, 2024 | Director |
SPRO | Spero Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
MGNX | MACROGENICS INC | May 21, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
MGNX | MACROGENICS INC | May 20, 2024 | 2 | $0 | 4 | May 22, 2024 | Director |
GLYC | GLYCOMIMETICS INC | May 1, 2024 | 1 | $0 | 4 | May 1, 2024 | Director |
MURA | Mural Oncology plc | Dec 14, 2023 | 1 | $0 | 4 | Dec 18, 2023 | Director |
MURA | Mural Oncology plc | Oct 31, 2023 | 0 | $0 | 3 | Nov 7, 2023 | Director |
SPRO | Spero Therapeutics, Inc. | Oct 5, 2023 | 1 | $0 | 4 | Oct 10, 2023 | Director |
MGNX | MACROGENICS INC | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
GLYC | GLYCOMIMETICS INC | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
SPRO | Spero Therapeutics, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director |
MGNX | MACROGENICS INC | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
GLYC | GLYCOMIMETICS INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
SPRO | Spero Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
GLYC | GLYCOMIMETICS INC | May 18, 2021 | 2 | $0 | 4 | May 27, 2021 | Director |
MGNX | MACROGENICS INC | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |